Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

Withdrawn before enrolling

Conditions studied: Leishmaniasis

In brief

This study is a prospective observational study in which patients undergoing treatment for leishmaniasis with miltefosine (Impavido) in the US and who weigh \> 75 kg can volunteer to provide information about their clinical response to treatment up to 6 months after the start of treatment.

Key facts

Study ID

NCT02429505

Run by

Knight Therapeutics (USA) Inc

People needed

0

Starts

2015-07-01

Expected to finish

2020-03-01

Last updated by the study team

2020-08-28

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Did the subject give consent to collect data from her or her physician?
• Was the subject treated for leishmaniasis with miltefosine?
• Does the subject weigh more than 75 kg?

You may not qualify if…

• [none]

Where it is running

• Fast-Track Drugs and Biologics, LLC — Poolesville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.